Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 8:17 pm Purchase | 2025-12-31 | 13G | OVID THERAPEUTICS INC OVID | ADAR1 Capital Management LLC | 9,284,166 6.900% | 9,284,166 (New Position) | Filing History |
| 2026-02-17 8:16 pm Purchase | 2025-12-31 | 13G | SPRUCE BIOSCIENCES INC SPRB | ADAR1 Capital Management LLC | 58,000 5.400% | 58,000 (New Position) | Filing History |
| 2026-02-17 8:15 pm Purchase | 2025-12-31 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | ADAR1 Capital Management LLC | 1,014,158 7.900% | 1,014,158 (New Position) | Filing History |
| 2026-02-17 8:14 pm Purchase | 2025-12-31 | 13G | QUOIN PHARMACEUTICALS LTD SPON QNRX | ADAR1 Capital Management LLC | 58,230 6.900% | 58,230 (New Position) | Filing History |
| 2026-02-17 8:13 pm Purchase | 2025-12-31 | 13G | ADAGIO MED INC ADGM | ADAR1 Capital Management LLC | 1,205,447 5.700% | 1,205,447 (New Position) | Filing History |
| 2026-02-17 6:23 pm Sale | 2025-12-31 | 13G | BIOAGE LABS INC BIOA | ADAR1 Capital Management LLC | 135,560 0.400% | -1,801,563 (-93.00%) | Filing History |
| 2026-02-17 6:22 pm Purchase | 2025-12-31 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | ADAR1 Capital Management LLC | 12,692,387 9.900% | 4,954,693 (+64.03%) | Filing History |
| 2026-02-17 6:20 pm Sale | 2025-12-31 | 13G | IBIO INC PAR $0.001 IBIO | ADAR1 Capital Management LLC | 1,351,671 4.400% | -442,384 (-24.66%) | Filing History |
| 2026-02-17 6:19 pm Sale | 2025-12-31 | 13G | PERCEPTIVE CAP SOLUTIONS CORP PCSC | ADAR1 Capital Management LLC | 456,720 5.100% | -293,280 (-39.10%) | Filing History |
| 2026-02-17 6:17 pm Purchase | 2025-12-31 | 13G | GRACE THERAPEUTICS, INC GRCE | ADAR1 Capital Management LLC | 1,648,791 9.900% | 114,537 (+7.47%) | Filing History |
| 2025-11-14 7:47 pm Sale | 2025-09-30 | 13G | PROTHENA CORP PLC SHS PRTA | ADAR1 Capital Management LLC | 1,469,098 2.700% | -1,905,911 (-56.47%) | Filing History |
| 2025-11-14 7:45 pm Purchase | 2025-09-30 | 13G | EQUILLIUM INC EQ | ADAR1 Capital Management LLC | 6,194,882 9.900% | 6,194,882 (New Position) | Filing History |
| 2025-11-14 7:44 pm Purchase | 2025-09-30 | 13G | ACASTI PHARMA INC NO PAR ACST | ADAR1 Capital Management LLC | 1,534,254 9.900% | 32,111 (+2.14%) | Filing History |
| 2025-10-15 06:50 am Sale | 2025-10-15 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management LLC | 0 0.000% | -5,389,264 (Position Closed) | Filing History |
| 2025-08-21 4:15 pm Sale | 2025-08-21 | 13D | KEROS THERAPEUTICS INC KROS | ADAR1 Capital Management LLC | 5,389,264 13.270% | -1,700 (-0.03%) | Filing History |
| 2025-08-14 9:13 pm Purchase | 2025-06-30 | 13G | IBIO INC PAR $0.001 IBIO | ADAR1 Capital Management LLC | 1,794,055 9.900% | 698,088 (+63.70%) | Filing History |
| 2025-08-14 8:27 pm Purchase | 2025-06-30 | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | ADAR1 Capital Management LLC | 7,737,694 9.900% | 743,448 (+10.63%) | Filing History |
| 2025-08-14 8:17 pm Purchase | 2025-06-30 | 13G | PROTHENA CORP PLC SHS PRTA | ADAR1 Capital Management LLC | 3,375,009 6.300% | 3,375,009 (New Position) | Filing History |
| 2025-08-14 8:07 pm Purchase | 2025-06-30 | 13G | BIOAGE LABS INC BIOA | ADAR1 Capital Management LLC | 1,937,123 5.400% | 1,937,123 (New Position) | Filing History |
| 2025-08-14 7:47 pm Purchase | 2025-06-30 | 13G | KIORA PHARMACEUTICALS INC KPRX | ADAR1 Capital Management LLC | 365,179 9.900% | 50,076 (+15.89%) | Filing History |